Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
42 U.S.C. 264 Regulations to control communicable diseases
42 U.S.C. 264 Regulations to control communicable diseases, “Regulations to control communicable diseases”, is a U.S. Code section of Part G—Quarantine and Inspection; in force.
https://ontology.bommaritollc.com/id/01a0f07c-da01-7612-a2fd-2f3800f7d8af
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 42 U.S.C. 264 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Regulations to control communicable diseasesen |
| schema:url | |
| skos:prefLabel | 42 U.S.C. 264 Regulations to control communicable diseasesen |
Related
Rules made under it (50)eli:based_on
- 21 CFR Part 101—Food labeling
- 21 CFR Part 10—Administrative practices and procedures
- 21 CFR Part 110—Current good manufacturing practice in manufacturing, packing, or holding human food
- 21 CFR Part 111—Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements
- 21 CFR Part 112—Standards for the growing, harvesting, packing, and holding of produce for human consumption
- 21 CFR Part 113—Thermally processed low-acid foods packaged in hermetically sealed containers
- 21 CFR Part 114—Acidified foods
- 21 CFR Part 115—Shell eggs
- 21 CFR Part 117—Current good manufacturing practice, hazard analysis, and risk-based preventive controls for human food
- 21 CFR Part 118—Production, storage, and transportation of shell eggs
- 21 CFR Part 120—Hazard Analysis and Critical Control Point (HACCP) systems
- 21 CFR Part 123—Fish and fishery products
- 21 CFR Part 1240—Control of communicable diseases
- 21 CFR Part 1250—Interstate conveyance sanitation
- 21 CFR Part 1271—Human cells, tissues, and cellular and tissue-based products
- 21 CFR Part 129—Processing and bottling of bottled drinking water
- 21 CFR Part 12—Formal evidentiary public hearing
- 21 CFR Part 13—Public hearing before a public board of inquiry
- 21 CFR Part 14—Public hearing before a public advisory committee
- 21 CFR Part 15—Public hearing before the Commissioner
- 21 CFR Part 1—General enforcement regulations
- 21 CFR Part 201—Labeling
- 21 CFR Part 207—Requirements for foreign and domestic establishment registration and listing for human drugs, including drugs that are regulated under a biologics license application, and animal drugs, and the national drug code
- 21 CFR Part 20—Public information
- 21 CFR Part 210—Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; general
- 21 CFR Part 211—Current good manufacturing practice for finished pharmaceuticals
- 21 CFR Part 25—Environmental impact considerations
- 21 CFR Part 26—Mutual recognition of pharmaceutical good manufacturing practice reports, medical device quality system audit reports, and certain medical device product evaluation reports: United States and the European Community
- 21 CFR Part 3—Product jurisdiction
- 21 CFR Part 4—Regulation of combination products
20 more
- 21 CFR Part 507—Current good manufacturing practice, hazard analysis, and risk-based preventive controls for food for animals
- 21 CFR Part 600—Biological products: general
- 21 CFR Part 601—Licensing
- 21 CFR Part 606—Current good manufacturing practice for blood and blood components
- 21 CFR Part 607—Establishment registration and product listing for manufacturers of human blood and blood products and licensed devices
- 21 CFR Part 610—General biological products standards
- 21 CFR Part 630—Requirements for blood and blood components intended for transfusion or for further manufacturing use
- 21 CFR Part 640—Additional standards for human blood and blood products
- 21 CFR Part 660—Additional standards for diagnostic substances for laboratory tests
- 21 CFR Part 680—Additional standards for miscellaneous products
- 21 CFR Part 740—Cosmetic product warning statements
- 21 CFR Part 7—Enforcement policy
- 21 CFR Part 807—Establishment registration and device listing for manufacturers and initial importers of devices
- 21 CFR Part 820 #2—Quality system regulation
- 21 CFR Part 820—Quality system regulation
- 21 CFR Part 861—Procedures for performance standards development
- 21 CFR Part 898—Performance standard for electrode lead wires and patient cables
- 42 CFR Part 70—Interstate quarantine
- 42 CFR Part 71—Foreign quarantine
- Delegation, FR Doc. 94-7248
Cited by (21)eli:cites
- 21 CFR 101.17 Food labeling warning, notice, and safe handling statements.
- 21 CFR 110.5 Current good manufacturing practice.
- 21 CFR 112.192 What is the applicability and status of this part?
- 21 CFR 115.50 Refrigeration of shell eggs held for retail distribution.
- 21 CFR 117.1 Applicability and status.
- 21 CFR 118.12 Enforcement and compliance.
- 21 CFR 16.5 Inapplicability and limited applicability.
- 21 CFR 507.1 Applicability and status.
- 21 CFR 820.250 Statistical techniques.
- 21 U.S.C. 2201 Performance standards
- 21 U.S.C. 356 Expedited approval of drugs for serious or life-threatening diseases or conditions
- 21 U.S.C. 381 Imports and exports
- 38 CFR 1.460 Definitions.
- 42 CFR 70.1 General definitions.
- 42 CFR 71.1 Scope and definitions.
- 42 CFR 71.32 Persons, carriers, and things.
- 42 U.S.C. 201 Definitions
- 42 U.S.C. 266 Special quarantine powers in time of war
- 42 U.S.C. 271 Penalties for violation of quarantine laws
- 49 CFR 173.134 Class 6, Division 6.2—Definitions and exceptions.
- 49 U.S.C. 24301 Status and applicable laws